Bleb creation and modification should be viewed as any other construction project, according to Dr Andrew Iwach.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Perfuse Therapeutics shares findings from glaucoma and diabetic retinopathy trials of PER-001
Phil Lai, MD, chief medical officer of Perfuse Therapeutics, said the company's goal is to pioneer disease-modifying treatment that targets an underlying pathology of ischemia
A new set of guidelines for implementing interventional glaucoma
The framework covers ocular hypertension to severe progression
Pinpointing a first-line treatment for glaucoma
Laser surgery is an appropriate adjunctive therapy across the continuum of glaucoma care, as well as a safe option for patients who also have cataracts and other complicating factors
Research indicates B vitamins and choline provide neuroprotection against glaucoma
Vitamins B6, B9 and B12 were found to be neuroprotective against retinal ganglion cell death
Rethinking race as a risk factor for glaucoma
Social determinants of health challenge our existing expectations
Nicox SA shares research findings from NCX 470 Mont Blanc Phase 3 glaucoma trial
The novel nitric oxide-donating bimatoprost eye drop is designed to lower IOP in patients with open-angle glaucoma or ocular hypertension